Screener / SEC EDGAR /CIK 0001124198 /10-K filed Feb 17, 2026, compared with Feb 18, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Industrials · Engineering & Construction

Fluor Corp FLR

Compare with peers Embed
The 10-K against last year's

108 changes: 36 added, 17 removed, 54 reworded, 1 quiet changes

10-K Feb 17, 2026 vs Feb 18, 2025

10-K 0001124198-26-000007 (Feb 17, 2026) vs 10-K 0001628280-25-005924 (Feb 18, 2025) Not compared: Accounting Policies.

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

176 paragraphs · 9 new · 44 reworded · 4 gone · 10-K Feb 17, 2026 against Feb 18, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 105 · 50% changed Every version of it
government •significant delays in funding appropriations, reductions in spending or a change and changes in budgetary priorities that could reduce demand for our services, cancel or delay federal projects, and result in the closure of federal facilities and significant personnel reductions. Changes in U.S. government priorities by the new U.S. presidential administration or congressional leadership, or other policy changes or economic changes, could adversely impact us. The U.S. government is under no obligation to maintain program funding at any specific level, and funds for a program may even be eliminated. Our U.S. government clients may terminate or decide not to renew our contracts with little or no prior notice. reductions;
Paragraph 1 · 44% changed Every version of it
We operate in a complex and rapidly changing global environment that involves numerous known and unknown risks and uncertainties that could materially adversely affect our business, financial condition, results of operations, and stock price. The risks described below highlight some of the factors that have affected and could affect us in the future. We may also be affected by unknown risks or risks that we currently think are immaterial. If any such events actually occur, our business, financial condition, results of operations, and stock price could be materially adversely affected. Some of the factors, events, and contingencies discussed below may have occurred in the past, and the disclosures below are not representations as to whether or not the factors, events or contingencies have occurred in the past, but are provided because future occurrences of such factors, events, or contingencies could have a material adverse effect.
Paragraph 104 · 42% changed Every version of it
We have a significant portfolio of U.S. federal government contracts, including those that we have in place with the DOE and U.S. Department of Defense. DOD. U.S. government contracts are subject to various uncertainties, restrictions and regulations, including oversight audits by government agencies and profit and cost controls, which could result in withholding or delay of payments to us. U.S. government contracts are also subject to uncertainties associated with congressional funding, including the potential impacts of budget deficits, government shutdowns and federal sequestration. A significant reduction in federal including, but not limited to:
Paragraph 158 · 40% changed Every version of it
We occasionally bring claims against clients and partners for additional costs exceeding the contract price or for amounts not included in the original contract price. Similarly, we present change orders and claims to our subcontractors and suppliers. If we fail to properly provide notice or document the nature of change orders or claims, or are otherwise unsuccessful in negotiating a reasonable settlement, we could incur reduced profits, cost overruns and in some cases a loss on the project. These types of claims can occur due to matters such as owner-caused delays or changes from the initial project scope, which result in additional cost. These claims can result in lengthy and costly proceedings, and it is often difficult to accurately predict when these claims will be fully resolved. When these types of events occur and while unresolved claims are pending, we may invest significant working capital in projects to cover cost overruns pending the resolution of the relevant claims. A failure to promptly recover on these types of claims could have a material adverse impact on our liquidity and financial results.
Paragraph 2 · 34% changed Every version of it
We operate in a complex and rapidly changing global environment that involves numerous known and unknown risks In evaluating our business, you should carefully consider the following discussion of material risks, events and uncertainties that could materially adversely affect our business, financial condition, results of operations, and stock price. make an investment in us speculative or risky in addition to other information in this Annual Report on Form 10-K. The risks described below highlight some of the factors that have affected and could affect us in the future. We may also be affected by unknown risks or risks that we currently think are immaterial. If any such events actually occur, our business, financial condition, results of operations, and stock price could be materially adversely affected. Some of the The disclosures below reflect our beliefs and opinions as to factors, events, events or contingencies that could materially and contingencies discussed below may have occurred adversely affect us and our securities in the past, future. References to past events are provided by way of example only and the disclosures below are not representations intended to be a complete listing or a representation as to whether or not the such factors, events or contingencies have occurred in the past, but are provided because future occurrences past or their likelihood of such factors, events, or contingencies could have a material adverse effect. occurring in the future.
Paragraph 76 · 33% changed Every version of it
Artificial intelligence, machine learning, data science and similar technologies (collectively, “AI”), including third-party AI tools, may be enabled by, or integrated into, some of our business processes and solutions. As with many developing technologies, AI presents risks and challenges that could affect its further development, adoption, and use, and therefore our business. AI algorithms may be flawed or biased. Datasets used to train or develop AI systems may be insufficient, of inferior quality, or contain biased information. Our AI governance review process and self-imposed requirement to implement safeguards before adopting AI may not be adequate to protect against these risks and challenges. Additionally, the laws and regulations concerning the use of AI continue to evolve. If the use or integration of AI systems, or the outputs generated by such systems, were determined to be non-compliant (e.g., in relation to IP or data privacy rights or in relation to the deployment of AI for certain activities or use cases), this may adversely affect us. It is possible that emerging regulations may limit or block the use of AI in our business or otherwise impose restrictions that may adversely affect the efficiency of our business processes or solutions that were utilizing AI technologies.
Paragraph 109 · 33% changed Every version of it
government spending or a change in budgetary priorities could reduce demand for our services, cancel or delay federal projects, and result in the closure of federal facilities and significant personnel reductions. Changes in U.S. government priorities by the new U.S. presidential administration or congressional leadership, or other policy changes or economic changes, could adversely impact us. The U.S. government is under no obligation to maintain program funding at any specific level, and funds for a program may even be eliminated. Our U.S. government clients may terminate or decide not to renew our contracts with little or no prior notice.
Paragraph 110 · 30% changed Every version of it
In addition, U.S. government contracts are subject to specific regulations such as the Federal Acquisition Regulation ("FAR"), the Truth in Negotiations Act, the Cost Accounting Standards ("CAS"), the Service Contract Act and Department of Defense security regulations. Failure to comply with any of these regulations and other government requirements may result in contract price adjustments, financial penalties or contract termination. Our U.S. government contracts are also subject to audits, cost reviews and investigations by U.S. government oversight agencies such as the U.S. Defense Contract Audit Agency (the "DCAA"). The DCAA reviews the adequacy of, and our compliance with, our internal controls and policies (including our labor, billing, accounting, purchasing, estimating, compensation and management information systems). The DCAA also has the ability to review how we have accounted for costs under the FAR and CAS. The DCAA presents its findings to the Defense Contract Management Agency ("DCMA"). Should the DCMA determine that we have not complied with the terms of our contract and applicable statutes and regulations, or if they believe that we have engaged in inappropriate accounting or other activities, payments to us may be disallowed or we could be required to refund previously collected payments. Additionally, we may be subject to criminal and civil penalties, suspension or debarment from future government contracts, and qui tam litigation brought by private individuals on behalf of the U.S. government under the False Claims Act, which could include claims for treble damages. These suits may remain under seal (and hence, be unknown to us) for some time while the government decides whether to intervene on behalf of the qui tam plaintiff. Furthermore, if we have significant disagreements with our government clients concerning costs incurred, negative publicity could arise, which could adversely affect our industry reputation and our ability to compete for new contracts in the government arena or otherwise.

MD&A

89 paragraphs · 27 new · 43 reworded · 13 gone · 10-K Feb 17, 2026 against Feb 18, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 22 · 49% changed
New awards and (3)During 2025, our backlog were lower in 2024 compared to 2023. New awards booked during 2024 included a full notice to proceed on a downstream project in Mexico. Backlog declined during 2024 decreased due to the execution pace exceeding new award activity. We booked a multi-billion dollar award for a life sciences project during 2025. We booked significant positive project adjustments related to scope increases on several large projects during the second quarter of 2025 and scope reductions on 2 large projects in the first quarter of 2025.
Paragraph 34 · 48% changed
Revenue declined during 2024 primarily increased in 2025 due to a decline in execution activity for several projects nearing completion, a deferral of revenue recognized on a large project due to reduced productivity and lower revenue on our refinery projects in Mexico as well as revenue on inflation-adjusted variable consideration recognized in 2023. The decreases in revenue during 2024 were partially offset by the ramp up of execution activities on 3 chemicals life sciences and mining and metal projects. The increase in 2025 revenue was partially offset by a decline in execution activity for recently completed projects and projects nearing completion. During 2025 and 2024, at-cost revenue for Urban Solutions was approximately $5 billion and $4 billion, respectively (or approximately 59% and 51% of their segment revenue).
Paragraph 68 · 48% changed
Our operating cash flow for 2024 2025 was significantly improved driven impacted by $642 million paid to Santos, net of insurance recoveries, upon a judgment over Santos’ efforts to recover costs related to a reimbursable project completed by us in 2015. This decline was partially offset by decreases in working capital on several large projects. The improvement in operating cash flow was also attributable to customer payments on several large projects, projects as well as distributions from a large Energy Solutions joint ventures of $367 million and refunds of $169 million, including interest, from the IRS attributable to the 2013 tax year that was originally recognized as a receivable in 2020 pursuant to the CARES Act. We also venture. During 2025, we funded an estimated $99 $74 million on loss projects during 2024. 2 consolidated infrastructure projects.
Paragraph 43 · 47% changed
Results for the fourth quarter of 2024. Segment profit and profit margin declined in the fourth quarter of 2024 significantly decreased 2025 primarily due to the favorable settlement recognition of revenue reserves for certain disputed costs on a DOD project and an adverse ruling on a long-standing claim on an international bridge for a project during 2023. completed in 2019.
Paragraph 25 · 46% changed
Revenue decreased in 2024 significantly 2025 primarily due to the reversal of previously recognized revenue of $643 million for a judgment on the long-completed Santos project in Australia as well as a decline in execution activity for Energy Solutions projects nearing completion. However, revenue in both Urban Solutions and Mission Solutions increased compared to 2023 primarily in 2025 due to the ramp up of execution activities on several recently awarded projects including two life sciences projects, and mining and metals projects and an increase in volume on a large metals project, a green steel project and a large mining DOE project.
Paragraph 41 · 46% changed
Results for the fourth quarter of 2024. 2025. Segment profit in the fourth quarter of 2024 significantly decreased due to 2025 was consistent with the favorable settlement fourth quarter of a claim on an international bridge project during 2023. 2024.
Paragraph 36 · 44% changed
New awards in 2024 2025 included a large life sciences project, an incremental award on a large metals project as well as several multi-billion dollar pharmaceutical facility, two significant contract extensions mining projects and construction contracts for Plant & Facility Services. 2 infrastructure projects. Backlog increased during 2024 in 2025 due to these 2 large awards. the new award activity. Our staffing business does not report new awards or backlog.
Paragraph 46 · 43% changed
Segment profit Prior to its deconsolidation in 2024 includes a $7 million charge for severance expected upon liquidation October 2024, the results of NuScale were presented in our Other segment. In 2025, we completed the sale of Stork's operations in Trinidad the U.K. and Tobago as well as recognized a gain on sale of $7 million compared to an $11 million gain on the sale of Stork's operations in continental Europe. We completed the sale of Stork's U.K. operations Europe in the first quarter of 2024. The results from our Other segment were immaterial for 2025. With the completion of the Stork U.K. divestiture, we expect the results of this segment to be immaterial in 2025.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Legal Proceedings394 words changed in this paragraph; it is 46% similar to last year's version.
Fluor Australia Ltd., our wholly-owned subsidiary (“Fluor Australia”), completed a cost reimbursable engineering, procurement and construction management services project for Santos Ltd. (“Santos”) involving a large network of natural gas gathering and processing facilities in Queensland, Australia. On December 13, 2016, Santos filed an action in Queensland Supreme Court (the “Court”) against Fluor Australia, asserting various causes of action and seeking damages and/or a refund of contract proceeds paid of AUD $ 1.47 billion. Santos has joined Fluor to the matter on the basis of a parent company guarantee issued for the project. In March On July 14, 2023, a panel of 3 referees appointed by the Court (the "Panel”) issued a draft, non-binding report setting forth recommendations to the Court regarding liability and damages in the lawsuit. After consideration of further submissions by the parties, the Panel finalized its report on July 14, 2023. The Panel’s report has no legal effect unless it is adopted by the Court through an adoption hearing, and the Court can accept or reject, in whole or in part, the Panel’s recommendations. In the final report, the Panel recommended judgment for Fluor on one of Santos’s damages claims that Santos contends has an approximate value of AUD $ 700 million, and recommended judgment for Santos on other claims that the Panel valued at approximately AUD $ 790 million excluding interest and costs. While the project contract contains a liability cap of approximately AUD $ 236 million, the Panel found that the liability cap did not apply to Santos’s claims. Fluor has made an application to have Following interim applications and hearings, in August 2025, the Court set aside generally accepted the reference recommendations of the panel of referees. In December 2025, we made a payment to Santos of $ 649 million, net of GST, in accordance with the Court’s orders. Santos’s legal fees will be assessed in a separate process. After allowing for committed insurance proceeds and reserves, we recognized a reduction to revenue of $ 643 million reflecting the net estimated impact of the judgment. Discussions with our insurers are ongoing and, if successful, may further reduce the ultimate obligation. We have appealed the court's decision to the Panel and Queensland Court of Appeal. The appeal hearing is currently scheduled to take place in July 2026. In mid-October 2025, five of our more than 30 insurers filed a complaint in the Panel’s recommendations on several procedural and substantive grounds, including in relation Superior Court of California, County of Orange, disputing coverage by seeking various declaratory judgments. We have reached an agreement with these carriers to apparent bias of dismiss the referees, action without prejudice subject to a failure to comply with the order which established the reference to the Panel and a lack of procedural fairness. In July 2023, the Court held oral argument on that application and reserved its decision. Pursuant to an application by Santos to adopt the Panel’s report, the Court then held an adoption hearing in February and March 2024 at which Fluor contended that the Court should not adopt the Panel’s recommendation based on numerous grounds, including the Panel’s failure to apply the project’s liability cap. The Court also reserved its decision at the close of the adoption hearing. We await the Court’s decisions on Fluor’s application to set aside the reference and Santos’s application to adopt the Panel’s report. standstill/tolling agreement.

Source: Item 3, via Note 11 – Contingencies and Commitments, 10-K 0001124198-26-000007 vs Item 3, via Note 10 – Contingencies and Commitments, 10-K 0001628280-25-005924

Risk Factors164 words changed in this paragraph; it is 63% similar to last year's version.
In addition, U.S. government contracts are subject to specific regulations such as the Federal Acquisition Regulation ("FAR"), the Truth in Negotiations Act, the Cost Accounting Standards ("CAS"), the Service Contract Act and Department of Defense security regulations. Failure to comply with any of these regulations and other government requirements may result in contract price adjustments, financial penalties or contract termination. Our U.S. government contracts are also subject to audits, cost reviews and investigations by U.S. government oversight agencies such as the U.S. Defense Contract Audit Agency (the "DCAA"). The DCAA reviews the adequacy of, and our compliance with, our internal controls and policies (including our labor, billing, accounting, purchasing, estimating, compensation and management information systems). The DCAA also has the ability to review how we have accounted for costs under the FAR and CAS. The DCAA presents its findings to the Defense Contract Management Agency ("DCMA"). Should the DCMA determine that we have not complied with the terms of our contract and applicable statutes and regulations, or if they believe that we have engaged in inappropriate accounting or other activities, payments to us may be disallowed or we could be required to refund previously collected payments. Additionally, we may be subject to criminal and civil penalties, suspension or debarment from future government contracts, and qui tam litigation brought by private individuals on behalf of the U.S. government under the False Claims Act, which could include claims for treble damages. These suits may remain under seal (and hence, be unknown to us) for some time while the government decides whether to intervene on behalf of the qui tam plaintiff. Furthermore, if we have significant disagreements with our government clients concerning costs incurred, negative publicity could arise, which could adversely affect our industry reputation and our ability to compete for new contracts in the government arena or otherwise.

Source: Item 1A, 10-K 0001124198-26-000007 vs Item 1A, 10-K 0001628280-25-005924

MD&A115 words changed in this paragraph; it is 78% similar to last year's version.
Year Ended December 31, (in millions) 2025 2024 2023 2022 OPERATING CASH FLOW FLOW(1) $ (387) $ 828 $ 212 $ 31 INVESTING CASH FLOW Proceeds from the sale of NuScale shares 605 — — Proceeds from sales and maturities (purchases) of marketable securities 75 (60) (141) (64) Capital expenditures (50) (164) (106) (75) NuScale cash deconsolidated — (131) — — Proceeds from sales of assets (net of cash divested) 63 82 (5) 95 Investments in partnerships and joint ventures (278) (93) (33) (53) Return of capital from partnerships and joint ventures 22 34 8 19 Other — (1) — — Investing cash flow 437 (333) (277) (78) FINANCING CASH FLOW Repurchase of common stock (754) (125) — — Proceeds from issuance of 2029 Notes, net of issuance costs — — 560 — Capped call transactions related to 2029 Notes — — (73) — Purchases and retirement of debt (37) (57) (249) (41) Proceeds from NuScale de-SPAC transaction share issuance (net of issuance fees) — — 341 Proceeds from sale of NuScale interest 80 — 107 Dividends paid on CPS — — (29) (39) Make-whole payment on conversion of CPS — — (27) — Distributions paid to NCI (64) (14) (53) (60) Capital contributions by NCI 65 — 10 21 Other (7) — (12) (14) Financing cash flow (797) (116) 127 315 Effect of exchange rate changes on cash 53 (69) 18 (38) Increase (decrease) in cash and cash equivalents (694) 310 80 230 Cash and cash equivalents at beginning of year 2,829 2,519 2,439 2,209 Cash and cash equivalents at end of year $ 2,135 $ 2,829 $ 2,519 $ 2,439 Cash paid during the year for: Interest $ 42 $ 53 $ 54 Income taxes (net of refunds) 13 169 99 Noncash investing and financing activities: Marketable securities transferred to trustee to discharge the 2024 Notes $ — $ 262 $ — Debt assumed by buyer of Stork Latin America — 19 —

Source: Item 7, 10-K 0001124198-26-000007 vs Item 7, 10-K 0001628280-25-005924

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of FLR's Risk Factors and MD&A, 10-K Feb 17, 2026 against 10-K Feb 18, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
•disruptions to departments or agencies (including as result of budget deficits, government shutdowns and federal sequestration) that could interrupt communications with departments and agencies, result in program cancellations, disruptions and/or stop work orders, limit the government’s ability to make timely payments, and limit our ability to perform under existing contracts and compete for new projects;
Read it in 10-K Feb 17, 2026 at sec.gov
AddedRisk Factors
Our ability to successfully execute strategic initiatives, including plans to monetize our remaining stake in NuScale, is subject to various risks and uncertainties, which may negatively impact the realization of expected benefits. We cannot predict the trading price of shares of NuScale's common stock and the market value of the NuScale shares are subject to market volatility and other factors beyond the control of us or NuScale, including general economic, financial and business
Read it in 10-K Feb 17, 2026 at sec.gov
AddedRisk Factors
conditions. We intend to complete the sale of our shares in NuScale by the end of Q2 2026, but there can be no assurance regarding the ultimate timing of such monetization process. Unanticipated developments could delay, prevent of otherwise adversely affect the monetization process, including but not limited to financial market conditions.
Read it in 10-K Feb 17, 2026 at sec.gov
Show the other 54
AddedRisk Factors
We are subject to numerous environmental laws and health and safety regulations. Our projects can involve the handling of hazardous and other highly regulated materials, including nuclear and other radioactive materials, which, if
Read it in 10-K Feb 17, 2026 at sec.gov
RemovedRisk Factors
•Our U.S. government contracts and contracting rights may be terminated or otherwise adversely impacted at any time, and our inability to win or renew government contracts during regulated procurement processes could harm our operations and reduce our projects and revenues.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedRisk Factors
Our U.S. government contracts and contracting rights may be terminated or otherwise adversely impacted at any time, and our inability to win or renew government contracts during regulated procurement processes could harm our operations and reduce our projects and revenues.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedRisk Factors
We have announced a number of strategic initiatives, including plans to reduce our ownership of NuScale and to finalize the divestitures of Stork. Our ability to successfully execute these initiatives is subject to various risks and uncertainties, including regulatory intervention, which may negatively impact the realization of expected benefits. Our failure to realize the anticipated benefits, which may be due to our inability to execute, competition, economic conditions, and other risks described herein, could have a material adverse effect on us. Divesting businesses involves risks and uncertainties, such as the difficulty separating assets related to such businesses from the businesses we retain, employee distraction, and the need to obtain regulatory approvals and other third-party consents, which potentially disrupts customer and vendor relationships. Such actions also involve significant costs and require time and attention from our management, which may divert attention from other business operations. Because of these challenges, as well as market conditions or other factors, anticipated divestitures may take longer or be costlier or generate fewer benefits than expected and may not be completed at all. If we are unable to complete the divestitures or to successfully transition divested businesses, our business and financial results could be negatively impacted. If we dispose of a business, we may not be able to successfully cause a buyer of a divested business to assume the liabilities of that business or, even if such liabilities are assumed, we may have difficulties enforcing our rights, contractual or otherwise, against the buyer. We may retain exposure on financial or performance guarantees and other contractual, employment, pension and severance obligations, and potential liabilities that may arise under law because of the disposition or the subsequent failure of an acquirer.
Read it in 10-K Feb 18, 2025 at sec.gov
RewordedRisk Factors
The policies and precautions we take to prevent and detect fraud, misconduct or failures to comply with applicable laws and regulations may not be effective, and we could face unknown risks or losses.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
Any of these or other events could cause system interruptions, delays, loss of critical or sensitive data (including personal or financial data) or loss of funds; could delay or prevent operations (including the processing of transactions and reporting of financial results); and could adversely affect us.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
Industries served by that segment and many of the others The end markets we serve have historically been and will continue to be vulnerable to general downturns, which in turn could materially and adversely affect the demand for our services.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
In addition, adverse credit and financial market conditions, including increasing or continued high interest rates potentially as a result to the Proposed Tariffs, rates, also adversely affect our clients' and our partners' borrowing capacity, which could result in contract cancellations or suspensions, project award and execution delays, payment delays or defaults by our clients.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
We may do not always win contracts that we have bid on due to for a variety of reasons such as price, a client's perception of our ability to perform and/or perceived technology advantages held by others.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
Our efforts to mitigate our business risks associated with climate change climate-related events and natural disasters cannot eliminate those risks, and we recognize that there are inherent climate related climate-related and environmental risks regardless of where we conduct our businesses.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
The direct physical risks that climate change poses through chronic climate-related events and environmental changes, issues pose, such as rising sea levels and temperatures, and acute events, such as hurricanes, droughts and wildfires, are common to each of these industries.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
The insurance we maintain that specifically covers cybersecurity threats may not sufficiently cover all types of losses or claims that we might experience, including losses from delays in our ability to provide services to our customers, reputational harm or the costs to improve security against future similar threats or losses arising from the computing environments and systems managed by others.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedRisk Factors
Loss of the services of, or failure to recruit, qualified technical and management personnel, including a preference by some candidates to work remotely, could limit our ability to successfully complete existing projects and compete for new projects.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedMD&A
We continue to see solid client engagement across our markets and a robust and diverse pipeline of opportunities, particularly where accelerated schedules and critical business needs are driving investment. While some clients are pacing commitments due to cost pressures or commodity price softness, our teams are actively advancing engineering and design work so projects can move quickly once final decisions are made. These timing shifts impacted 2025 results, but we remain focused on disciplined execution, cost management, and positioning our clients for long‑term success.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedMD&A
Revenue, profit and operating cash flow in 2025 was significantly impacted by a judgment on the long completed Santos project in Australia. We have appealed the Court decision and we are also working with our insurance carriers to address the obligations arising from the judgment and the costs related to the appeal. We recognized a reversal of revenue of $643 million during 2025, inclusive of committed insurance proceeds, representing the net payment to Santos made in the fourth quarter of 2025.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedMD&A
We slowed our execution activities at our joint venture in Mexico beginning in the second quarter of 2025 through much of the third quarter to minimize our working capital exposure to the joint venture's primary customer. The customer made significant progress payments through December 2025, which allowed us to execute a controlled restart of our project execution activities.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedMD&A
Prior to November 2025, we converted 15 million of our 126 million NuScale voting shares (along with the associated ownership units in NuScale's operating subsidiary) into registered shares and sold all 15 million of those shares for net proceeds of $605 million. We converted the remaining 111 million of our NuScale voting shares (along with the associated ownership units in NuScale's operating subsidiary) into registered shares upon reaching agreement with NuScale in November 2025, including the following general attributes:
Read it in 10-K Feb 17, 2026 at sec.gov
AddedMD&A
In November 2025, through an indirect, wholly-owned subsidiary, we entered into a variable price forward sale agreement whereby we pledged and granted a security interest in 71 million of our remaining shares in NuScale, while maintaining continuing involvement and ownership rights, and committed to sell, convey, transfer, assign and deliver those shares at the final settlement date in the first quarter of 2026. Through our bank's execution, we completed the sale of all 71 million shares of NuScale on February 13, 2026, generating total proceeds of $1.35 billion. We expect to monetize the remaining 40 million shares of NuScale via similar structured programs and expect that all remaining ownership in NuScale should be sold by the second quarter of 2026.
Read it in 10-K Feb 17, 2026 at sec.gov
AddedMD&A
In December 2025, we reached an agreement to sell our ownership in the fabrication yard in China for approximately $122 million. The sale is expected to close in 2026, subject to the conditions in the agreement.
Read it in 10-K Feb 17, 2026 at sec.gov
RemovedMD&A
In the first quarter of 2024, we completed the sale of Stork's operations in continental Europe. During April 2024, we also entered into a definitive agreement to sell Stork's U.K. operations, which we completed in the first quarter of 2025. The sale did not meet the requirements for discontinued operations as of December 31, 2024 and will not have a material impact on the financial statements. In the third quarter of 2024, we decided to close our Stork operations in Trinidad and Tobago which required us to take a $7 million severance charge. After completing the wind down of the Trinidad and Tobago operations, Stork's divestiture will be complete.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
Beginning in October 2024, based principally on their equity sales, we no longer met the criteria to consolidate NuScale. As a consequence, their results for all periods prior to October 2024 were consolidated, but we deconsolidated NuScale after that date and recognized a pre-tax gain of $1.6 billion in the fourth quarter of 2024, based on a stock price of $13.15 for our 126 million shares. We recognize the fair value of our investment in NuScale on a mark-to-market basis based upon the prevailing price of their stock on our balance sheet dates, which resulted in an additional pre-tax gain of $604 million for the fourth quarter of 2024. After its deconsolidation, NuScale is included in equity method earnings on our statement of operations.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
Consolidated revenue increased in 2024 primarily driven by an increase in execution activities on several recently awarded projects in our Urban Solutions segment partially offset by revenue declines in Energy Solutions and Mission Solutions.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
Earnings before taxes significantly improved in 2024 driven by an increase in execution activities on recently awarded life sciences and mining projects as well as the completion or resolution of certain legacy projects in 2024, partially offset by declines in profit due to the recognition of inflation-adjusted variable consideration on certain projects in 2023. The improvement in earnings before taxes in 2024 was also attributable to losses recognized in 2023 on the sales of our AMECO and Stork businesses in Latin America. Further, earnings before taxes in 2024 included a foreign currency gain compared to a loss in 2023.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
In 2024, we received refunds of $169 million, including interest, from the IRS attributable to the 2013 tax year that was originally recognized as a receivable in 2020 pursuant to the CARES Act.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
Beginning in January 2024, many non-US tax jurisdictions have enacted or are in the process of enacting legislation to adopt a minimum effective tax rate described in the Global Anti-Base Erosion Model Rules, also known as Pillar Two. Pillar Two establishes a global minimum tax of 15% on large multinational corporations. We considered the applicable tax law changes in the countries in which we operate and have determined that there is no material impact to our tax provision in 2024. We will continue to evaluate the impact of these tax law changes on future periods.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
We are one of the larger technical and professional services firms providing engineering and design, project management, procurement, construction, operations and maintenance, and fabrication and modularization services.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
Segment profit declined in 2024 primarily due to the initial recognition of inflation-adjusted variable consideration on certain downstream projects during 2023. Segment profit in 2024 was also impacted by cost growth related to schedule delays and reduced productivity on a large project in the late stages of execution. We recognized a positive adjustment upon the negotiation of change orders on the same project in 2023. Further, cost growth on a construction-only subcontract executed by our joint venture in Mexico resulted in charges totaling $66 million during 2024. The decrease in segment profit during 2024 was partially offset by final negotiations and handover of a large upstream legacy project which was completed during the second quarter of 2024. We recorded $91 million for cost growth on the now-completed project during 2023. Segment profit in 2024 also included gains of $47 million on embedded foreign currency derivatives compared to a loss of $17 million in 2023. The changes in segment profit margin in 2024 reflect these same factors.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
Segment profit and profit margin significantly improved during 2024 primarily due to the recognition of a $30 million charge in 2023 for cost growth associated with schedule delays on a weapons facility project that is now complete. The increase in segment profit and profit margin in 2024 was further driven by improved performance on 2 DOE contracts in 2024, partially offset by the cancellation of the aforementioned project.
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
Other includes the operations of NuScale prior to deconsolidation and the operations of the remaining Stork and AMECO business prior to their sale.YEAR ENDED DECEMBER 31, (in millions) 2024 2023 2022 NuScale (1) $ (100) $ (106) $ (73) Stork 23 (55) 45 AMECO (1) (67) 1 Segment profit (loss) $ (78) $ (228) $ (27) (1)NuScale expenses included in the determination of segment profit were as follows: NuScale expenses $ (196) $ (246) $ (179) Less: DOE reimbursable expenses 12 64 74 NuScale expenses, net (184) (182) (105) Less: Attributable to NCI 84 76 32 NuScale profit (loss) $ (100) $ (106) $ (73)
Read it in 10-K Feb 18, 2025 at sec.gov
RemovedMD&A
Segment profit in 2023 includes a $60 million negative earnings impact on the sale of our AMECO South America business (including $35 million for foreign currency translation) and a $93 million negative earnings impact on the sale of our Stork business in Latin America (including cash paid to the buyer of $31 million and $33 million for foreign currency translation).
Read it in 10-K Feb 18, 2025 at sec.gov
RewordedMD&A
YEAR ENDED DECEMBER 31, (in millions) 2025 2024 2023 2022 Revenue Revenue(1) Urban Solutions $ 9,200 $ 7,239 $ 5,262 $ 4,373 Energy Solutions 3,554 5,976 6,307 5,872 Mission Solutions 2,720 2,594 2,655 2,289 Other 29 506 1,250 1,210 Total revenue $ 15,503 $ 16,315 $ 15,474 $ 13,744 Segment profit (loss) $ and margin % Urban Solutions $ 205 2.2% $ 304 4.2% $ 268 5.1% $ 17 0.4% Energy Solutions (414) NM 256 4.3% 381 6.0% 301 5.1% Mission Solutions 94 3.5% 153 5.9% 116 4.4% 136 5.9% Other 6 NM (78) NM (228) NM (27) NM Total segment profit (loss) $ and margin %(1) %(2) $ (109) (0.7)% $ 635 3.9% $ 537 3.5% $ 427 3.1% G&A (196) (203) (232) (237) Impairment — — 24 Gain on pension settlement — — 42 Foreign currency gain (loss) (62) 92 (98) 25 Interest income (expense), net 67 150 168 35 Earnings (loss) attributable to NCI (11) (61) (60) (72) Earnings (loss) before taxes (311) 613 315 244 Income tax expense benefit (expense) (including $376 $92 million and $(376) million attributable to equity method earnings in 2024) 2025 and 2024, respectively) 39 (634) (236) (171) Net earnings (loss) before equity method earnings (272) (21) 79 73 Equity method earnings 210 2,105 — — Net earnings (loss) (62) 2,084 79 73 Less:
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Year Ended December 31, (in millions) 2025 2024 2023 2022 OPERATING CASH FLOW FLOW(1) $ (387) $ 828 $ 212 $ 31 INVESTING CASH FLOW Proceeds from the sale of NuScale shares 605 — — Proceeds from sales and maturities (purchases) of marketable securities 75 (60) (141) (64) Capital expenditures (50) (164) (106) (75) NuScale cash deconsolidated — (131) — — Proceeds from sales of assets (net of cash divested) 63 82 (5) 95 Investments in partnerships and joint ventures (278) (93) (33) (53) Return of capital from partnerships and joint ventures 22 34 8 19 Other — (1) — — Investing cash flow 437 (333) (277) (78) FINANCING CASH FLOW Repurchase of common stock (754) (125) — — Proceeds from issuance of 2029 Notes, net of issuance costs — — 560 — Capped call transactions related to 2029 Notes — — (73) — Purchases and retirement of debt (37) (57) (249) (41) Proceeds from NuScale de-SPAC transaction share issuance (net of issuance fees) — — 341 Proceeds from sale of NuScale interest 80 — 107 Dividends paid on CPS — — (29) (39) Make-whole payment on conversion of CPS — — (27) — Distributions paid to NCI (64) (14) (53) (60) Capital contributions by NCI 65 — 10 21 Other (7) — (12) (14) Financing cash flow (797) (116) 127 315 Effect of exchange rate changes on cash 53 (69) 18 (38) Increase (decrease) in cash and cash equivalents (694) 310 80 230 Cash and cash equivalents at beginning of year 2,829 2,519 2,439 2,209 Cash and cash equivalents at end of year $ 2,135 $ 2,829 $ 2,519 $ 2,439 Cash paid during the year for:
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
G&AYEAR ENDED DECEMBER 31, (in millions) 2025 2024 2023 2022 G&A Compensation $ 99 $ 143 $ 165 $ 145 Severance and restructuring costs 43 13 11 Legal & professional fees 24 13 10 Facilities 7 15 14 16 Exit costs 13 6 7 SEC investigation — 1 38 Reserve for legacy legal claims 4 — 3 5 Severance — 5 1 Gain on sale of land and buildings — — (11) All other 32 38 36 Other 19 19 29 G&A $ 196 $ 203 $ 232 $ 237
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Make-whole payment on conversion of CPS — — 27 — Net earnings (loss) available to Fluor common stockholders $ (51) $ 2,145 $ 83 $ 106 New awards Urban Solutions $ 8,688 $ 9,493 $ 10,141 $ 6,900 Energy Solutions 1,421 3,246 6,871 6,512 Mission Solutions 1,847 1,910 1,055 5,347 Other — 474 1,461 1,056 Total new awards $ 11,956 $ 15,123 $ 19,528 $ 19,815 New awards related to projects located outside of the U.S. 26 % 38 % 76 % 46 % (in millions) December 31, 2024 2025 December 31, 2023 2024 Backlog (2)(3) (3)(4) Urban Solutions $ 18,746 $ 17,749 $ 14,848 Energy Solutions 4,601 7,605 9,722 Mission Solutions 2,189 2,727 3,945 Other — 403 926 Total backlog $ 25,536 $ 28,484 $ 29,441 Backlog related to projects located outside of the U.S. 40 % 55 % 62 % Backlog related to reimbursable projects 81 % 79 % 76 %
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Segment profit in 2024 includes a $7 million charge for severance expected upon liquidation In 2025, we completed the sale of Stork's operations in Trinidad the U.K. and Tobago as well as recognized a gain on sale of $7 million compared to an $11 million gain on the sale of Stork's operations in continental Europe. Europe in 2024.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
The decrease in net interest income during 2024 2025 was primarily due to a decrease in 2024 interest rates earned on cash deposits including at our joint ventures in Canada and Mexico as well as the interest savings following the extinguishment cash balances at certain of our 2024 Notes at the end of 2023. larger joint ventures.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Income tax expense benefit (expense) attributable to equity method earnings 376 92 (376) Income tax expense and effective tax rate, excluding amount attributable to equity method earnings (53) (17)% (258) 42% Net earnings (loss) excluding amount attributable to equity method earnings $ 355 (364) $355 Equity method earnings $ 2,105 210 $2,105 Income tax expense benefit (expense) and effective tax rate attributable to equity method earnings 92 (44)% (376) 18% Equity method earnings, net of related income tax expense $ 1,729 302 $1,729 Net earnings (loss) $ 2,084 (62) $2,084
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Segment profit in the fourth quarter of 2024 significantly 2025 decreased due to the favorable settlement recognition of revenue reserves for certain disputed costs on a claim on an international bridge project during 2023. DOD project.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
As of December 31, 2024, 2025, letters of credit totaling $483 $424 million were outstanding under our $1.8 $2.2 billion credit facility, which was amended matures in February 2025 to increase the facility to $2.2 billion and extend the maturity to February 2028.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Capital expenditures in 2024 were 2025 primarily related to investments in IT compared to expenditures for improvements to our new office lease in Houston compared to expenditures for construction equipment and investments in IT in 2023. 2024.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
These amounts Cash and cash equivalents held by our consolidated variable interest entities (which totaled $333 $328 million and $491 $333 million as of December 31, 2024 2025 and 2023, 2024, respectively) were not necessarily readily available for general purposes.
Read it in 10-K Feb 17, 2026 at sec.gov
RewordedMD&A
Over 28,000,000 10 million shares could still be purchased under the repurchase program as of December 31, 2024. 2025, but in February 2026 our board authorized a 30 million share expansion to the repurchase program.
Read it in 10-K Feb 17, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/FLR/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.